# Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.

Study · id `cardio:ct-nct02132026` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02132026](<https://clinicaltrials.gov/study/NCT02132026>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02132026

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 152 participants.

## Technical summary

Registry record NCT02132026. Randomized; quadruple masking; primary purpose treatment. Start 2014-11-12 (actual); primary completion 2019-11-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 152 participants (enrolled count; ClinicalTrials.gov record NCT02132026, source copy `cardio:ctgov-nct02132026-2021-10-14`, retrieved 2026-10-26)
- Started: 2014-11-12 (actual) (ClinicalTrials.gov record NCT02132026, source copy `cardio:ctgov-nct02132026-2021-10-14`, retrieved 2026-10-26)
- Primary completion: 2019-11-28 (actual) (ClinicalTrials.gov record NCT02132026, source copy `cardio:ctgov-nct02132026-2021-10-14`, retrieved 2026-10-26)
- Completion: 2019-11-28 (actual) (ClinicalTrials.gov record NCT02132026, source copy `cardio:ctgov-nct02132026-2021-10-14`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT02132026, source copy `cardio:ctgov-nct02132026-2021-10-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02132026-2021-10-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
- Acronym: SALTIRE II
- Condition: Calcific Aortic Stenosis
- Intervention (Drug): Denosumab
- Intervention (Drug): Alendronic Acid
- Intervention (Drug): Denosumab Placebo
- Intervention (Drug): Alendronic Acid Placebo
- Lead sponsor: University of Edinburgh
- Lead sponsor class: OTHER
- Collaborator: British Heart Foundation
- Collaborator class: OTHER
- Collaborator: NHS Lothian
- Collaborator class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: University of Edinburgh (`cardio:org-university-of-edinburgh`)
- Registry lists this organization as a collaborator: British Heart Foundation (`cardio:org-british-heart-foundation`)
- Registry lists this organization as a collaborator: NHS Lothian (`cardio:org-nhs-lothian`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Denosumab or Alendronic Acid on the Progression of Aortic Stenosis: A Double-Blind Randomized Controlled Trial (`cardio:pubmed-33913339`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Denosumab or Alendronate on Vascular Calcification: Secondary Analysis of SALTIRE2 Randomized Controlled Trial (`cardio:pubmed-39248270`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial (`cardio:pubmed-40050004`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Artificial Intelligence-Enabled Echocardiography as a Surrogate for Multimodality Aortic Stenosis Imaging: Post Hoc Analysis of a Clinical Trial (`cardio:pubmed-41473954`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 42d048efe7f3ac090e271abe8dfed362b14d00f4ef7c1e30987b3e7fd221dbba
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
